Does Rallies show 13F holders for RCKT?

Yes. Rallies tracks hedge fund and 13F ownership data for RCKT, including fund names, share counts, latest tracked quarter, and position changes when available.

Is RCKT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for RCKT. It does not provide personalized investment advice.

RCKT (Rocket Pharmaceuticals, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Rocket Pharmaceuticals, Inc. Common Stock (RCKT) is a publicly traded Healthcare sector company. As of May 21, 2026, RCKT trades at $3.05 with a market cap of $335.22M and a P/E ratio of -1.47. RCKT moved +1.37% today. Year to date, RCKT is -16.34%; over the trailing twelve months it is -56.64%. Its 52-week range spans $2.19 to $18.89. Analyst consensus is buy with an average price target of $9.67. Rallies surfaces RCKT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns RCKT stock?

Hedge funds tracked by Rallies that own RCKT include Maverick Capital, Panagora Asset, and A16Z Perennial. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Rocket Pharmaceuticals, Inc. Common Stock.

RCKT Key Metrics

Key financial metrics for RCKT
Metric	Value
Price	$3.05
Market Cap	$335.22M
P/E Ratio	-1.47
EPS	$-2.01
Dividend Yield	0.00%
52-Week High	$18.89
52-Week Low	$2.19
Volume	820
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-223.12M
Gross Margin	0.00%

Top Hedge Funds Holding RCKT

Maverick Capital holds 3.57M shares of RCKT, changed +41.95% as of Mar 31, 2026.
Panagora Asset holds 348.80K shares of RCKT, changed +0.00% as of Dec 31, 2025.
A16Z Perennial holds 11.34K shares of RCKT, changed +0.00% as of Mar 31, 2026.

Latest RCKT News

Rocket Pharmaceuticals Sells $180M Rare Disease Review Voucher, Extends Cash Runway to 2028 — Apr 28, 2026
Rocket Pharmaceuticals Narrows Q4 Loss, Holds $188.9M Cash as Kresladi Decision Looms — Feb 27, 2026

Recent RCKT Insider Trades

Wilson Martin sold 3.36K (~$12.12K) on May 13, 2026.
Shah Gaurav sold 2.73K (~$9.84K) on May 13, 2026.
Militello John sold 855 (~$3.08K) on May 13, 2026.

RCKT Analyst Consensus

13 analysts cover RCKT: 0 strong buy, 7 buy, 4 hold, 2 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.67.

Common questions about RCKT

Who owns RCKT stock?: Hedge funds tracked by Rallies that own RCKT include Maverick Capital, Panagora Asset, and A16Z Perennial. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Rocket Pharmaceuticals, Inc. Common Stock.
Does Rallies show 13F holders for RCKT?: Yes. Rallies tracks hedge fund and 13F ownership data for RCKT, including fund names, share counts, latest tracked quarter, and position changes when available.
Is RCKT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for RCKT. It does not provide personalized investment advice.